{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:31Z","timestamp":1761489871132},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100000864","name":"The Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0523-x","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T12:42:01Z","timestamp":1450874521000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of augmenting cholinergic function on gait and balance"],"prefix":"10.1186","volume":"15","author":[{"given":"Martina","family":"Mancini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett W.","family":"Fling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Gendreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay B.","family":"Horak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"523_CR1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.20513","volume":"20","author":"GA Kang","year":"2005","unstructured":"Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B. Clinical characteristics in early Parkinson\u2019s disease in a central California population-based study. Mov Disord. 2005;20:1133\u201342.","journal-title":"Mov Disord"},{"key":"523_CR2","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/mds.21598","volume":"22","author":"RM Pickering","year":"2007","unstructured":"Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson\u2019s disease. Mov Disord. 2007;22:1892\u2013900.","journal-title":"Mov Disord"},{"key":"523_CR3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jnnp.72.6.721","volume":"72","author":"BH Wood","year":"2002","unstructured":"Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson\u2019s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72:721\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"523_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ageing\/21.1.32","volume":"21","author":"O Johnell","year":"1992","unstructured":"Johnell O, Melton 3rd LJ, Atkinson EJ, O\u2019Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing. 1992;21:32\u20138.","journal-title":"Age Ageing"},{"key":"523_CR5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mds.10396","volume":"18","author":"AL Adkin","year":"2003","unstructured":"Adkin AL, Frank JS, Jog MS. Fear of falling and postural control in Parkinson\u2019s disease. Mov Disord. 2003;18:496\u2013502.","journal-title":"Mov Disord"},{"key":"523_CR6","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","volume":"70","author":"D Muslimovic","year":"2008","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ, Group CS. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008;70:2241\u20137.","journal-title":"Neurology"},{"key":"523_CR7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1179\/1743132811Y.0000000044","volume":"33","author":"MS Bryant","year":"2011","unstructured":"Bryant MS, Rintala DH, Hou JG, Charness AL, Fernandez AL, Collins RL, et al. Gait variability in Parkinson\u2019s disease: influence of walking speed and dopaminergic treatment. Neurol Res. 2011;33:959\u201364.","journal-title":"Neurol Res"},{"key":"523_CR8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.26269","volume":"30","author":"C Curtze","year":"2015","unstructured":"Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa is a double-edged sword for balance and gait in people with Parkinson\u2019s disease. Mov Disord. 2015;30:1361\u201370.","journal-title":"Mov Disord"},{"key":"523_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0022-510X(92)90111-W","volume":"111","author":"FB Horak","year":"1992","unstructured":"Horak FB, Nutt JG, Nashner LM. Postural inflexibility in parkinsonian subjects. J Neurol Sci. 1992;111:46\u201358.","journal-title":"J Neurol Sci"},{"key":"523_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00415-010-5789-8","volume":"258","author":"S Lord","year":"2011","unstructured":"Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. Gait variability in Parkinson\u2019s disease: an indicator of non-dopaminergic contributors to gait dysfunction? J Neurol. 2011;258:566\u201372.","journal-title":"J Neurol"},{"key":"523_CR11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.0b013e3181f61329","volume":"75","author":"RJ St George","year":"2010","unstructured":"St George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010;75:1292\u20139.","journal-title":"Neurology"},{"key":"523_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.parkreldis.2008.01.006","volume":"14","author":"JO Rinne","year":"2008","unstructured":"Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson\u2019s disease is related to disability of the patients. Parkinsonism Relat Disord. 2008;14:553\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"523_CR13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","volume":"81","author":"NI Bohnen","year":"2013","unstructured":"Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, et al. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 2013;81:1611\u20136.","journal-title":"Neurology"},{"key":"523_CR14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","volume":"253","author":"NI Bohnen","year":"2006","unstructured":"Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia. J Neurol. 2006;253:242\u20137.","journal-title":"J Neurol"},{"key":"523_CR15","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, Muller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009;73:1670\u20136.","journal-title":"Neurology"},{"key":"523_CR16","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","volume":"120","author":"C Karachi","year":"2010","unstructured":"Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. 2010;120:2745\u201354.","journal-title":"J Clin Invest"},{"key":"523_CR17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","volume":"75","author":"KA Chung","year":"2010","unstructured":"Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75:1263\u20139.","journal-title":"Neurology"},{"key":"523_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11055-008-9077-3","volume":"38","author":"IV Litvinenko","year":"2008","unstructured":"Litvinenko IV, Odinak MM, Mogil\u2019naya VI, Emelin AY. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson\u2019s disease (an open controlled trial). Neurosci Behav Physiol. 2008;38:937\u201345.","journal-title":"Neurosci Behav Physiol"},{"key":"523_CR19","unstructured":"HIller AP, Nutt JG, Mancini M, Horak FB, Kareus S, Schoneburg BM, et al. Are cholinesterase inhibitors effective in improving balance in Parkinson\u2019s disease? J Neurol Disord. 2015; In press"},{"key":"523_CR20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","volume":"27","author":"B Dubois","year":"2012","unstructured":"Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, et al. Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord. 2012;27:1230\u20138.","journal-title":"Mov Disord"},{"key":"523_CR21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/mds.22856","volume":"25","author":"KA Chung","year":"2010","unstructured":"Chung KA, Lobb BM, Nutt JG, McNames J, Horak F. Objective measurement of dyskinesia in Parkinson\u2019s disease using a force plate. Mov Disord. 2010;25:602\u20138.","journal-title":"Mov Disord"},{"key":"523_CR22","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/mds.23362","volume":"25","author":"KL Chou","year":"2010","unstructured":"Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, et al. A recommended scale for cognitive screening in clinical trials of Parkinson\u2019s disease. Mov Disord. 2010;25:2501\u20137.","journal-title":"Mov Disord"},{"key":"523_CR23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370.","journal-title":"Mov Disord"},{"key":"523_CR24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"523_CR25","doi-asserted-by":"crossref","first-page":"M28","DOI":"10.1093\/gerona\/50A.1.M28","volume":"50A","author":"LE Powell","year":"1995","unstructured":"Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci. 1995;50A:M28\u201334.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"523_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing. 1997;26:353\u20137.","journal-title":"Age Ageing"},{"key":"523_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1743-0003-2-19","volume":"2","author":"JM Hausdorff","year":"2005","unstructured":"Hausdorff JM. Gait variability: methods, modeling and meaning. J Neuroeng Rehabil. 2005;2:19.","journal-title":"J Neuroeng Rehabil"},{"key":"523_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bandc.2009.02.002","volume":"70","author":"J Fan","year":"2009","unstructured":"Fan J, Gu X, Guise KG, Liu X, Fossella J, Wang H, et al. Testing the behavioral interaction and integration of attentional networks. Brain Cogn. 2009;70:209\u201320.","journal-title":"Brain Cogn"},{"key":"523_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuroimage.2005.02.004","volume":"26","author":"J Fan","year":"2005","unstructured":"Fan J, McCandliss BD, Fossella J, Flombaum JI, Posner MI. The activation of attentional networks. Neuroimage. 2005;26:471\u20139.","journal-title":"Neuroimage"},{"issue":"Pt 2","key":"523_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1469-7793.2000.t01-1-00503.x","volume":"523","author":"H Tokimura","year":"2000","unstructured":"Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol. 2000;523(Pt 2):503\u201313.","journal-title":"J Physiol"},{"key":"523_CR31","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/brain\/aws207","volume":"135","author":"L Rochester","year":"2012","unstructured":"Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B, et al. Cholinergic dysfunction contributes to gait disturbance in early Parkinson\u2019s disease. Brain. 2012;135:2779\u201388.","journal-title":"Brain"},{"key":"523_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s002210000543","volume":"135","author":"V Lazzaro Di","year":"2000","unstructured":"Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res. 2000;135:455\u201361.","journal-title":"Exp Brain Res"},{"key":"523_CR33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00221-005-2228-7","volume":"163","author":"R Nardone","year":"2005","unstructured":"Nardone R, Florio I, Lochner P, Tezzon F. Cholinergic cortical circuits in Parkinson\u2019s disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. Exp Brain Res. 2005;163:128\u201331.","journal-title":"Exp Brain Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0523-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T02:24:09Z","timestamp":1498271049000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2377\/15\/264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0523-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"264"}}